| |
| |
|
| Insider
Information: |
Milligan John F |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,574,306 |
|
|
Indirect Shares
|
211,755 |
|
|
| Direct
Value |
$103,132,786 |
|
|
|
Indirect Value
|
$7,321,070 |
|
|
| Total
Shares |
1,786,061 |
|
|
| Total
Value |
$110,453,856 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
President and CEO, Dir... |
2018-11-27 |
1,574,306 |
2012-01-06 |
111,755 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
Director |
2020-12-15 |
0 |
2020-12-15 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FDMT |
4d Molecular Therapeutics... |
Director |
– • – |
2020-12-15 |
4 |
B |
$23.00 |
$2,300,000 |
I/I |
100,000 |
100,000 |
2.1 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2018-11-27 |
4 |
OE |
$23.60 |
$6,608,000 |
D/D |
280,000 |
1,574,306 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2018-05-04 |
4 |
OE |
$27.07 |
$2,165,600 |
D/D |
80,000 |
1,294,306 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2018-02-21 |
4 |
D |
$80.69 |
$646,246 |
D/D |
(8,009) |
1,214,306 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
56,051 |
1,222,315 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2018-02-15 |
4 |
A |
$62.35 |
$21,198 |
D/D |
340 |
1,166,264 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2017-11-13 |
4 |
AS |
$72.88 |
$16,034,678 |
D/D |
(220,000) |
1,165,924 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2017-11-13 |
4 |
OE |
$21.58 |
$4,746,500 |
D/D |
220,000 |
1,385,924 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2017-02-23 |
4 |
OE |
$21.58 |
$2,157,500 |
D/D |
100,000 |
1,165,924 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,035 |
1,074,313 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2017-02-16 |
4 |
D |
$70.31 |
$589,831 |
D/D |
(8,389) |
1,065,924 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2017-02-15 |
4 |
A |
$59.33 |
$18,689 |
D/D |
315 |
1,059,278 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-09-06 |
4 |
AS |
$77.74 |
$5,442,080 |
D/D |
(70,000) |
1,058,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-09-06 |
4 |
OE |
$20.74 |
$1,451,800 |
D/D |
70,000 |
1,128,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-08-01 |
4 |
AS |
$70.94 |
$4,965,590 |
D/D |
(70,000) |
1,058,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-08-01 |
4 |
OE |
$20.74 |
$1,451,800 |
D/D |
70,000 |
1,128,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-07-05 |
4 |
AS |
$84.28 |
$9,444,921 |
D/D |
(112,000) |
1,058,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-07-05 |
4 |
OE |
$16.40 |
$1,836,240 |
D/D |
112,000 |
1,170,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-06-06 |
4 |
OE |
$16.40 |
$1,836,240 |
D/D |
112,000 |
1,170,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-06-06 |
4 |
AS |
$86.57 |
$9,736,779 |
D/D |
(112,000) |
1,058,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-05-02 |
4 |
AS |
$87.27 |
$9,823,954 |
D/D |
(112,000) |
1,058,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-05-02 |
4 |
OE |
$16.40 |
$1,836,240 |
D/D |
112,000 |
1,170,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-04-04 |
4 |
AS |
$94.54 |
$10,593,904 |
D/D |
(112,000) |
1,058,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2016-04-04 |
4 |
OE |
$16.40 |
$1,836,240 |
D/D |
112,000 |
1,170,963 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President, COO and Director |
• • – |
2016-03-01 |
4 |
AS |
$87.79 |
$9,832,995 |
D/D |
(112,000) |
1,058,963 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
